| 5-HT | serotonin (5-hydroxytryptamine) |
| ALS | amyotrophic lateral sclerosis |
| ASM | antiseizure medication |
| BDNF | brain-derived neurotrophic factor |
| BIC | bicuculline |
| BiP | immunoglobulin-binding protein |
| BRIEF | Behavior Rating Index of Executive Function |
| CA3 | cornu ammonis subfield 3 |
| CaM | calmodulin |
| CDD | CDKL5-associated disorder |
| CNS | central nervous system |
| DEE | developmental and epileptic encephalopathy |
| DHEA | dehydroepiandrosterone |
| DHEAS | dehydroepiandrosterone sulfate |
| EEG | electroencephalogram/electroencephalographic |
| ER | endoplasmic reticulum |
| FTLD | frontotemporal lobar dementia |
| GABA | γ-aminobutyric acid |
| GTC | generalized tonic-clonic |
| GTPase | hydrolase enzyme of guanosine triphosphate |
| HINT1 | histidine triad nucleotide binding protein 1 (HINT1) |
| i.c.v. | intracerebroventricular |
| iNOS | inducible nitric oxide synthase |
| IP3R | inositol triphosphate receptor |
| LFP | local field potential |
| MAM | mitochondria-associated membrane |
| mTOR | mechanistic target of rapamycin |
| NFκB | nuclear factor κB |
| NMDA | N-methyl-d-aspartate |
| NMDAR | N-methyl-d-aspartate receptor |
| OCD | obsessive-compulsive disorder |
| PNS | peripheral nervous system |
| PREGS | pregnenolone sulfate |
| PTZ | pentylenetetrazol |
| ROS | reactive oxygen species |
| Sigma1R | sigma-1 receptor |
| SNRI | serotonin-norepinephrine reuptake inhibitor |
| SSRI | selective serotonin reuptake inhibitor |
| SUDEP | sudden unexpected death in epilepsy |
| TRP | transient receptor potential |
| UTR | untranslated region |